Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Kingella kingae

ABSTRACT: Whole genome sequenceing of Kingella kingae isolates from New Zealand.

PROVIDER: PRJNA644230 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	JACBKT01.dat.gz	Other
	JACBKT01.fasta.gz	Fasta.gz
	JACBKT01.master.dat	Other
	JACBKU01.dat.gz	Other

Items per page:

1 - 5 of 10

Similar Datasets

Kingella kingae

Project description:Kingella kingae overview

| PRJNA53093 | ENA

Kingella kingae KKC2005004457

Project description:Kingella kingae KKC2005004457 Genome sequencing

| PRJNA174413 | ENA

Kingella kingae 11220434

Project description:Kingella kingae 11220434 Genome sequencing and assembly

| PRJNA88539 | ENA

Kingella kingae strain:F41215CHC

Project description:Kingella kingae strain:F41215CHC Genome sequencing

| PRJNA577516 | ENA

Kingella kingae strain:KKGP01

Project description:Kingella kingae strain:KKGP01 Genome sequencing

| PRJNA1097560 | ENA

Kingella kingae PYKK081

Project description:Genome sequence of Kingella kingae septic arthritis isolate PYKK081

| PRJNA85111 | ENA

Kingella negevensis shares multiple putative virulence factors with Kingella kingae.

Project description:Kingella negevensis is a newly described gram-negative bacterium in the Neisseriaceae family and is closely related to Kingella kingae, an important cause of pediatric osteoarticular infections and other invasive diseases. Like K. kingae, K. negevensis can be isolated from the oropharynx of young children, although at a much lower rate. Due to the potential for misidentification as K. kingae, the burden of disease due to K. negevensis is currently unknown. Similarly, there is little known about virulence factors present in K. negevensis and how they compare to virulence factors in K. kingae. Using a variety of approaches, we show that K. negevensis produces many of the same putative virulence factors that are present in K. kingae, including a polysaccharide capsule, a secreted exopolysaccharide, a Knh-like trimeric autotransporter, and type IV pili, suggesting that K. negevensis may have significant pathogenic potential.

| S-EPMC7598479 | biostudies-literature

Genomic comparison of Kingella kingae strains.

Project description:Kingella kingae is a betaproteobacterium from the order Neisseriales, and it is an agent of invasive infections in children. We sequenced the genome from the septic arthritis strain 11220434. It is composed of a 1,990,794-bp chromosome but no plasmid, and it contains 2,042 protein-coding genes and 52 RNA genes, including 3 rRNA genes.

| S-EPMC3486087 | biostudies-literature

Kingella

Project description:Kingella sp. overview

| PRJNA917418 | ENA

Broad-spectrum biofilm inhibition by Kingella kingae exopolysaccharide.

Project description:Cell-free extracts prepared from Kingella kingae colony biofilms were found to inhibit biofilm formation by Aggregatibacter actinomycetemcomitans, Klebsiella pneumoniae, Staphylococcus aureus, Staphylococcus epidermidis, Candida albicans, and K. kingae. The extracts evidently inhibited biofilm formation by modifying the physicochemical properties of the cell surface, the biofilm matrix, and the substrate. Chemical and biochemical analyses indicated that the biofilm inhibition activity in the K. kingae extract was due to polysaccharide. Structural analyses showed that the extract contained two major polysaccharides. One was a linear polysaccharide with the structure →6)-α-d-GlcNAcp-(1→5)-β-d-OclAp-(2→, which was identical to a capsular polysaccharide produced by Actinobacillus pleuropneumoniae serotype 5. The second was a novel linear polysaccharide, designated PAM galactan, with the structure →3)-β-d-Galf-(1→6)-β-d-Galf-(1→. Purified PAM galactan exhibited broad-spectrum biofilm inhibition activity. A cluster of three K. kingae genes encoding UDP-galactopyranose mutase (ugm) and two putative galactofuranosyl transferases was sufficient for the synthesis of PAM galactan in Escherichia coli. PAM galactan is one of a growing number of bacterial polysaccharides that exhibit antibiofilm activity. The biological roles and potential technological applications of these molecules remain unknown.

| S-EPMC3147541 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data